VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $100,000 | -40.1% | 10,100 | -34.3% | 0.00% | – |
| Q2 2022 | $167,000 | -37.7% | 15,372 | -35.2% | 0.00% | – |
| Q1 2022 | $268,000 | -15.7% | 23,704 | +16.8% | 0.00% | -100.0% |
| Q4 2021 | $318,000 | -73.6% | 20,300 | -71.1% | 0.00% | -75.0% |
| Q3 2021 | $1,203,000 | +158.7% | 70,139 | +224.5% | 0.00% | +100.0% |
| Q2 2021 | $465,000 | +72.9% | 21,617 | +31.9% | 0.00% | 0.0% |
| Q4 2019 | $269,000 | -57.4% | 16,388 | -32.2% | 0.00% | -60.0% |
| Q4 2018 | $632,000 | +229.2% | 24,180 | +187.9% | 0.01% | +400.0% |
| Q3 2018 | $192,000 | -86.8% | 8,400 | -91.2% | 0.00% | -85.7% |
| Q4 2017 | $1,453,000 | +24116.7% | 95,500 | +23775.0% | 0.01% | – |
| Q1 2017 | $6,000 | -98.8% | 400 | -98.8% | 0.00% | -100.0% |
| Q4 2016 | $510,000 | +7185.7% | 32,000 | +7900.0% | 0.00% | – |
| Q3 2016 | $7,000 | -81.6% | 400 | -91.1% | 0.00% | – |
| Q1 2016 | $38,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |